Trial site
National Hospital Organization Osaka Toneyama Medical Center
Toyonaka-shi, 560-8552, JapanNot linked to an institution yet
The trials here
What the 4 trials at this site are about, from their registry records.
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Dyne Therapeutics1 trial
- Sarepta Therapeutics, Inc.1 trial
Running trials
Recruiting
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
NCT07486934· Phase 3· Dyne Therapeutics· Source
Contact: Tsuyoshi Matsumura, MD, PhD
Active, not recruiting
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)
NCT05881408· Phase 3· Sarepta Therapeutics, Inc.· Source
Active, not recruiting
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
NCT05388669· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT04487080· Phase 3· Janssen Research & Development, LLC· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error